BARBARA THOMPSON: Open Payments
NPI 1447587837 · TINLEY PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,012 in 104 payments from 40 companies in 2025. Trend: 2023 $1,484 · 2024 $657 · 2025 $3,012
Food & beverage: $2,314Long term medical supply or device loan: $698
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $825 |
| Celgene Corporation | 9 | $293 |
| AstraZeneca Pharmaceuticals LP | 10 | $243 |
| Merck Sharp & Dohme LLC | 8 | $185 |
| GlaxoSmithKline, LLC. | 8 | $144 |
| ABBVIE INC. | 4 | $92 |
| GENZYME CORPORATION | 3 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $76 |
| BeOne Medicines USA, Inc. | 3 | $67 |
| Janssen Biotech, Inc. | 3 | $67 |
Products named: KISQALI, REBLOZYL, KEYTRUDA, OJJAARA, Epkinly, ELAHERE, CARVYKTI, LIBTAYO.
Industry payments across IL — which companies pay providers there.
